Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
INSYS Therapeutics Inc
Age
1–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Meets protocol-specified criteria for qualification and contraception, including treatment-resistant seizure disorder
Is able to speak and understand the language in which the study is being conducted, is able to understand the procedures and study requirements and has voluntarily signed and dated an informed consent form approved by the Institutional Review Board before the conduct of any study procedure
In the opinion of the Investigator, the participants and parent(s)/caregiver(s) are willing and able to comply with the study procedures and visit schedules, including venipuncture, inpatient stay at the study center, dosing at the study center twice a day as needed while an outpatient), and the Follow-up Visits (if applicable)
You may not be if
Participant or parent(s)/caregiver(s) have daily commitments during the study duration that would interfere with attending all study visits
History or current use of dietary supplements, drugs or over-the counter medications outside protocol-specified parameters
Signs, symptoms or history of any condition that, per protocol or in the opinion of the investigator, might compromise:
1. the safety or well-being of the participant or study staff
2. the safety or well-being of the participant's offspring (such as through pregnancy or breast-feeding)
3. the analysis of results
Clareo Health | Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders
